Literature DB >> 20645056

The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies.

Marie-Jeanne Marion1, Olivier Hantz, David Durantel.   

Abstract

Liver progenitor cells may play an important role in carcinogenesis in vivo and represent therefore useful cellular materials for in vitro studies. The HepaRG cell line, which is a human bipotent progenitor cell line capable to differentiate toward two different cell phenotypes (i.e., biliary-like and hepatocyte-like cells), has been established from a liver tumor associated with chronic hepatitis C. This cell line represents a valuable alternative to ex vivo cultivated primary human hepatocytes (PHH), as HepaRG cells share some features and properties with adult hepatocytes. The cell line is particularly useful to evaluate drugs and perform drug metabolism studies, as many detoxifying enzymes are expressed and functional. It is also an interesting tool to study some aspect of progenitor biology (e.g., differentiation process), carcinogenesis, and the infection by some pathogens for which the cell line is permissive (e.g., HBV infection). Overall, this chapter gives a concise overview of the biological properties and potential applications of this cell line.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645056     DOI: 10.1007/978-1-60761-688-7_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  35 in total

1.  Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.

Authors:  Piyanuch Wonganan; Kristina Jonsson-Schmunk; Shellie M Callahan; Jin Huk Choi; Maria A Croyle
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

2.  Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.

Authors:  Ahmed Diab; Adrien Foca; Floriane Fusil; Thomas Lahlali; Pascal Jalaguier; Fouzia Amirache; Lia N'Guyen; Nathalie Isorce; François-Loïc Cosset; Fabien Zoulim; Ourania Andrisani; David Durantel
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

Review 3.  A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.

Authors:  A S Khazali; A M Clark; A Wells
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

4.  Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells.

Authors:  Ludovic Aillot; Marc Bonnin; Malika Ait-Goughoulte; Nathalie Bendriss-Vermare; Sarah Maadadi; Laura Dimier; Miroslava Subic; Caroline Scholtes; Isabel Najera; Fabien Zoulim; Julie Lucifora; David Durantel
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  Transcription factor 19 interacts with histone 3 lysine 4 trimethylation and controls gluconeogenesis via the nucleosome-remodeling-deacetylase complex.

Authors:  Sabyasachi Sen; Sulagna Sanyal; Dushyant Kumar Srivastava; Dipak Dasgupta; Siddhartha Roy; Chandrima Das
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

6.  In vitro models for liver toxicity testing.

Authors:  Valerie Y Soldatow; Edward L Lecluyse; Linda G Griffith; Ivan Rusyn
Journal:  Toxicol Res (Camb)       Date:  2012-11-23       Impact factor: 3.524

7.  Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

Authors:  Baptiste Jammart; Maud Michelet; Eve-Isabelle Pécheur; Romain Parent; Birke Bartosch; Fabien Zoulim; David Durantel
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

8.  Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature.

Authors:  Reba Condiotti; Daniel Goldenberg; Hilla Giladi; Temima Schnitzer-Perlman; Simon N Waddington; Suzanne Mk Buckley; Denise Heim; Wing Cheung; Matthew Themis; Charles Coutelle; Alina Simerzin; Emma Osejindu; Henning Wege; Michael Themis; Eithan Galun
Journal:  Mol Ther       Date:  2013-08-28       Impact factor: 11.454

9.  Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.

Authors:  Thomas Lahlali; Jan Martin Berke; Karen Vergauwen; Adrien Foca; Koen Vandyck; Frederik Pauwels; Fabien Zoulim; David Durantel
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

10.  Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment.

Authors:  William D Hedrich; Jingwei Xiao; Scott Heyward; Yao Zhang; Junran Zhang; Maria R Baer; Hazem E Hassan; Hongbing Wang
Journal:  Mol Cancer Ther       Date:  2016-01-28       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.